OnKure Therapeutics, Inc. (NASDAQ:OKUR)
| Market Cap | 87.47M-28.3% |
| Revenue (ttm) | 0 |
| Net Income | -58.70M+16.4% |
| EPS | -3.50+33.3% |
| Shares Out | 40.50M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 132,316 |
| Open | 2.34 |
| Previous Close | 2.35 |
| Day's Range | 2.13 - 2.34 |
| 52-Week Range | 2.13 - 5.38 |
| Beta | 0.30 |
| Analysts | Buy |
| Price Target | 14.00(+548.15%) |
| Earnings Date | Nov 5, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About OKUR
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$OKUR stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in OKUR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by OKUR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
OKUR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New OKUR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to OKUR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in OKUR
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $4.19M |
| IWMiShares Russell 2000 ETF | $1.36M |
| VXFVanguard Extended Market ETF | $1.11M |
| VTWOVanguard Russell 2000 ETF | $547.73K |
| TMEDT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF | $229.23K |
| IWCiShares Micro-Cap ETF | $194.89K |
Estimated from each fund’s disclosed top holdings × AUM
OKUR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from OKUR’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score